...Doruk Arslan; Zeynep Ergul-Ulger; Sibel Goksen; Gunes Esendagli; Sevim Erdem-Ozdamar; Ersin Tan; Can Ebru Bekircan-Kurt Introduction: Contribution of T helper 1 and 2 cells-related cytokines to pathogenesis of myasthenia gravis (MG) is well known. Recently, the contribution of follicular T helper...

... in refractory myasthenia gravis patients. Methods: Patients with refractory myasthenia gravis treated with rituximab for more than 2 years were included. Rituximab was administered when CD20 + B cells were greater than 1%. We analysed the efficacy of rituximab, treatment interval, side effects, prognosis...

...Usha K. Misra; Jayantee Kalita; Varun K. Singh; Aditya Kapoor; Abhilasha Tripathi; Prabhakar Mishra Introduction: There is a lack of evidence about the usefulness of exercise or rest in myasthenia gravis (MG). This study is aimed to evaluate the efficacy and safety of exercise or rest in MG...

...Ahmad R. Abuzinadah; Mohammed H. Alanazy; Nadeem S. Butt; Richard J. Barohn; Mazen M. Dimachkie Objective: The aim of the study was to estimate the exacerbation incidence rate (IR) in acetylcholine receptor antibody (AChR)-positive generalized myasthenia gravis (MG) and its predictors. Methods...

... Ayguasanosa Background: Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission. Exacerbations may involve increasing bulbar weakness and/or sudden respiratory failure, both of which can be critically disabling. Management of MG exacerbations includes plasma exchange...

...Monica F. Ataide; Carolina da Cunha-Correia; Katia C.L. Petribú Background: Restless legs syndrome (RLS) is characterized for an uncomfortable sensation in legs and an irresistible desire to move them. This disorder has been more recently recognized in patients with myasthenia gravis (MG) and can...

...Florencia Aguirre; Andres M. Villa Background: We investigated the prognosis of patients with myasthenia gravis (MG) initially presenting with only ocular symptoms in an Argentinian population. Summary: We performed a retrospective analysis of 61 patients with MG with pure ocular involvement...

...Ozlem Gungor-Tuncer; Vuslat Yilmaz; Alper Toker; Guher Saruhan-Direskeneli; Yesim Gulsen-Parman; Piraye Oflazer-Serdaroglu; Feza Deymeer Background: The difficult course of patients with myasthenia gravis (MG) with anti-muscle-specific tyrosine kinase antibodies (MuSK) has been emphasized. However...

...Yun Jing; Xinxin Liu; Lei Yu; Ran Li Aims: To compare the long-term outcomes of non-thymomatous myasthenia gravis (MG) patients receiving pre-thymectomy (Pre-CS) or post-thymectomy corticosteroid (Post-CS) therapy. Methods: In a retrospective cohort study, 41 patients with MG were treated with Pre...

...Feng Jing; Fang Cui; Zhaohui Chen; Fei Yang; Li Ling; Xusheng Huang Objective: We investigated the correlation between disease severity and electrophysiological characteristics in 77 Chinese myasthenia gravis (MG) patients. Materials and Methods: Disease severity was assessed and compared...

... accuracy was 10%. Dry eye syndrome, conjunctivitis/keratitis and myasthenia gravis caused the most confusion in the differential diagnosis. Regular botulinum toxin type A injections improved both eyelid spasms and subjective ocular symptoms in all patients. Conclusions: Regular botulinum toxin type...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Myasthenia gravis Dear Sir, We respond to five suggestions from the viewpoint of anesthesiologists regarding...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Myasthenia gravis Dear Sir, Postoperative respiratory insufficiency after...

...Can Ebru Bekircan-Kurt; Aslı Tuncer Kurne; Sevim Erdem-Ozdamar; Umut Kalyoncu; Rana Karabudak; Ersin Tan Background: Systemic lupus erythematosus (SLE) is one of the autoimmune diseases, which is rarely reported with Myasthenia Gravis (MG). In the literature, the clinical features of MG...

...Hiroshi Kataoka; Takao Kiriyama; Takeshi Kawaguchi; Nobuhiro Sawa; Kazuma Sugie; Hirosei Horikawa; Takashi Tojo; Satoshi Ueno Background: Postoperative respiratory insufficiency (PRI) in myasthenia gravis (MG) often occurs within several days after thymectomy and remains problematic. In limited...

...Yusuke Shimizu; Shigeaki Suzuki; Kimiaki Utsugisawa; Tomihiro Imai; Hiroyuki Murai; Yuriko Nagane; Emiko Tsuda; Tomohisa Nagasao; Hisao Ogata; Masaki Yazawa; Norihiro Suzuki; Kazuo Kishi 23 07 2013 27 10 2013 5 2 2014 Myasthenia gravis Dear Sir, Myasthenia gravis...

...Andoni Echaniz-Laguna; Cristina Pistea; Nathalie Philippi; Irina Enache; Monique Oswald-Mammosser; Jérome De Sèze; Anne Charloux Aims: The aim of this study was to evaluate the proportion of patients with treated myasthenia gravis (MG) who present with dyspnea not related to MG. Methods: We...

...Mariusz Sieminski; Małgorzata Bilińska; Walenty M. Nyka Background/Aims: The objective of this study was to assess the prevalence of restless legs syndrome (RLS) in patients with myasthenia gravis (MG). Methods: We interviewed 73 MG patients and 65 healthy controls by using a structured diagnostic...

.... In multiple sclerosis, higher serum MMP-3 is seen during relapses. Lower serum MMP-8 and -9 levels correlate with fewer contrast-enhanced T 2 -weighted MRI lesions, and serum MMP-9 can be used in monitoring treatment. In myasthenia gravis, serum MMP-2, -3, and -9 levels are elevated in both generalized...

...Fredrik Romi; Geir Helgeland; Nils Erik Gilhus Heat-shock proteins (HSPs) are antigen-presenting protein-aggregation-preventing chaperones, induced by cellular stress in eukaryotic cells. In this review, we focus on recent HSP advances in neurological disorders. In myasthenia gravis, patients...